Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · operational-macro

IR Update: FDA Clears New Device for Liver Embolization Procedures

24 September 2026 · By · Wire by Fusion42

Published

24 September 2026

Topic

operational-macro

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at diagnosticimaging.com →

◆ Verified

Fusion42 · 24 September 2026 · Fusion42 review

The FDA granted 510(k) clearance for the TriNav Advance device by TriSalus Life Sciences, which supports improved access to small distal vessels for liver embolization procedures with configurations tailored to vessel anatomy and treatment needs.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

You can now target treatment of difficult liver vessels more precisely without extra tools, opening new opportunities to improve patient outcomes and reduce procedure complexity in embolization therapies.

◆ Coverage

1 source · 24 Sep 2026

◆ Related on Wire

◆ Topics

Medtechfda-clearancemedical-deviceliver-embolizationmedtechinterventional-radiology